EN – New CEO appointment

February 4, 2010 Group News

Arnoud van Tulder appointed Chief Executive

Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, has appointed Arnoud van Tulder (48) as Chief Executive Officer with effect from 1 May 2010. Arnoud, currently Chief Financial Officer of Cryo-Save, will succeed Marc Waeterschoot (60), who will remain on the Board as an Executive Director.

Johan Goossens, Cryo-Save Chairman said:

Arnoud has already made a huge contribution to Cryo-Save as CFO, steering us through listing both on AIM and Euronext, embarking on a successful investment and acquisition strategy and taking us into sustained growth. We look forward to his continued success as Chief Executive.



Enquiries

Cryo-Save Group
+ 31 (0) 575 548 998
Marc Waeterschoot, Chief Executive
Arnoud van Tulder, Chief Financial Officer

Daniel Stewart & Company plc
+ 44 (0) 20 7776 6550
Simon Leathers / Emma Earl

College Hill
+ 44 (0) 20 7457 2020
Adrian Duffield/Rozi Morris

Related Articles